Celgene Corporation is a global integrated biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases in patients with limited treatment options.
There are hundreds of clinical trials at major medical centers evaluating compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma (MM), myelodysplastic syndromes (MDS), chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), pancreatic cancer, non-small lung cancer and melanoma.
In addition, several compounds are being evaluated as therapies for serious inflammatory diseases such as psoriasis and psoriatic arthritis.
Current Team (6)Update
Executive Vice President and Chief Financial Officer
Senior Vice President of Business Development
Executive Vice President, Global Head Hematology and Oncology / Chief Commercial Officer
Chairman and Chief Executive Officer / Director
CEO, Celgene Cellular Therapeutics (CCT) and EVP, Chief Operations Officer
Switzerland – Boudry
Route de Perreux 1 Boudry
86 Morris Avenue
Summit, NJ 07901